Medication Abortion Via Pharmacy Dispensing

PHASE4CompletedINTERVENTIONAL
Enrollment

326

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

July 4, 2020

Study Completion Date

July 4, 2020

Conditions
Pregnancy RelatedAbortion Early
Interventions
DRUG

Mifepristone

Patients will receive Mifeprex® (mifepristone) by pharmacy rather than standard care at clinic visit

OTHER

Training on mifepristone dispensing

Pharmacists were offered a training on medication abortion and mifepristone dispensing

Trial Locations (6)

92103

Women's Health Services at University of California San Diego, San Diego

94115

Kaiser Permanente Northern California, San Francisco

Mt. Zion Women's Options Clinic, University, San Francisco

95817

Obstetrics and Gynecology Family Planning Clinic at University of California Davis, Sacramento

98105

University of Washington, Seattle

98405

Planned Parenthood Great Northwest, Hawai'i, Alaska, Indiana, Kentucky, Tacoma

All Listed Sponsors
collaborator

University of California, San Diego

OTHER

collaborator

University of California, Davis

OTHER

collaborator

University of Washington

OTHER

collaborator

Kaiser Permanente

OTHER

collaborator

Planned Parenthood of the Great Northwest and Hawaiian Islands

OTHER

lead

Daniel Grossman

OTHER

NCT03320057 - Medication Abortion Via Pharmacy Dispensing | Biotech Hunter | Biotech Hunter